MOBI Stock Chart & Stats
$11.34
--
Market closed
$11.34
--
Day’s Range― - ―
52-Week Range$8.03 - $15.29
Previous CloseN/A
VolumeN/A
Average Volume (3M)236.52K
Market Cap
$375.19M
Enterprise Value$277.37M
Total Cash (Recent Filing)$177.09M
Total Debt (Recent Filing)$8.43M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
Nov 05, 2026EPS Estimate
-0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.64
Shares Outstanding33,291,096
10 Day Avg. Volume151,664
30 Day Avg. Volume236,517
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-2.29
Price to Sales (P/S)10.79
P/FCF Ratio-7.51
Enterprise Value/Market Cap0.74
Enterprise Value/Revenue10.84
Enterprise Value/Gross Profit13.10
Enterprise Value/Ebitda-7.90
Forecast
1Y Price Target
$16.50Price Target Upside45.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-2.95
Revenue Forecast (FY)$55.04M
MOBI FAQ
What was Mobia Medical, Inc.’s price range in the past 12 months?
Mobia Medical, Inc. lowest stock price was $8.03 and its highest was $15.29 in the past 12 months.
What is Mobia Medical, Inc.’s market cap?
Mobia Medical, Inc.’s market cap is $375.19M.
When is Mobia Medical, Inc.’s upcoming earnings report date?
Mobia Medical, Inc.’s upcoming earnings report date is Nov 05, 2026 which is in 6 days.
How were Mobia Medical, Inc.’s earnings last quarter?
Mobia Medical, Inc. released its earnings results on Aug 11, 2026. The company reported -$1.1 earnings per share for the quarter, missing the consensus estimate of -$0.707 by -$0.393.
Is Mobia Medical, Inc. overvalued?
According to Wall Street analysts Mobia Medical, Inc.’s price is currently Undervalued.
Does Mobia Medical, Inc. pay dividends?
Mobia Medical, Inc. does not currently pay dividends.
What is Mobia Medical, Inc.’s EPS estimate?
Mobia Medical, Inc.’s EPS estimate is -0.46.
How many shares outstanding does Mobia Medical, Inc. have?
Mobia Medical, Inc. has 33,291,096 shares outstanding.
What happened to Mobia Medical, Inc.’s price movement after its last earnings report?
Mobia Medical, Inc. reported an EPS of -$1.1 in its last earnings report, missing expectations of -$0.707. Following the earnings report the stock price went down -8.426%.
Which hedge fund is a major shareholder of Mobia Medical, Inc.?
Currently, no hedge funds are holding shares in MOBI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Mobia Medical, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$16.50 (45.50% Upside)
$16.50 (45.50% Upside)
Blogger Sentiment
Bullish
MOBI Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $995.3K over
the Last 3 Months
the Last 3 Months
Fundamentals
Return on Equity
79.74%
Trailing 12-Months
Asset Growth
―
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Mobia Medical, Inc.
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
MOBI Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlights strong commercial traction (102% YoY revenue growth), high gross margins, expanding geographic footprint (active territories +92%), robust clinical evidence and a successful IPO that leaves the company well-capitalized ($177.1M cash incl. $134M IPO proceeds). Offsetting factors include a larger reported net loss ($21.0M), materially higher SG&A/R&D as the company scales, certain one-time accounting/timing items, and the fact that broader payer coverage remains a multi-year process (the New Tech APC is proposed but not final). On balance, operational momentum, reimbursement progress and a strengthened balance sheet outweigh the near-term expense-driven losses and coverage work still required.View all MOBI earnings summariesMOBI Stock 12 Month Forecast
Average Price Target
$16.50
▲(45.50% Upside)
Technical Analysis
ENvue Medical Inc
―
Shoulder Innovations, Inc.
―
MiniMed Group, Inc.
―
Alamar Biosciences, Inc.
―
Seaport Therapeutics, Inc.
―
Ownership Overview
18.68% Insiders
1.70% Mutual Funds
0.02% Other Institutional Investors
76.92% Public Companies and
Individual Investors





